A View of the Biochemistry Laboratory - Marker Gene Technologies, Inc

OUR SENIOR STAFF

Dr. John Naleway
President, CEO of MGTI -- Ph.D. Biochemistry, Adjunct faculty member in the Departments of Chemistry and Molecular Biology at the University of Oregon.

Timothy L. McCutcheon
Legal Counsel -- MS Biology, J.D., University of Oregon, corporate and patent attorney with extensive science background.

Michael P. Coughlin
Director of Business Development. MBA University of Oregon Business School, Sr. Partner in AmEuro, LLC and former CEO of Percon, Inc.

Dr. Anthony P. Guzikowski
Chemistry Director -- Adjunct Faculty member in the Department of Chemistry at the University of Oregon.

Daniel J. Coleman
B.S. in Biology from the University of Oregon, Enzymatic assays, metabolism, stability and distribution assay development.

Marker Gene Technologies, Inc. was founded in 1993 at the University of Oregon Riverfront Research Park to develop new products for the biotechnology and medical industries. The company has received a number of competitive grant awards for its work in cancer research and therapeutics from the National Institutes of Health as well as funding from the National Science Foundation for new uses of Marker Genes for agricultural biotechnology, cell culturing, bacteriology and basic research applications. Contact us for more information about our work in these areas.

The company has a staff of highly trained professionals with expertise in the areas of carbohydrate chemistry and biology; organic synthesis; fluorescence chemistry; molecular biology; DNA sequencing; subcloning; Northern blotting; Western blotting; cell culture; gel electrophoresis of DNA, RNA, and proteins; cell viability assays; bacterial detection; and related areas.

Mainpage | Research | Product | Contact | MGT Jobs